Incretin-based therapies in psychiatry: A landscape analysis of ongoing randomized trials registered on ClinicalTrials.gov
J Psychiatr Res. 2026 Oct 21;204:372-379. doi: 10.1016/j.jpsychires.2026.10.039. Online ahead of print.ABSTRACTBACKGROUND: Incretin-based therapies, including conventional glucagon-like peptide-1 receptor agonists (GLP-1RAs) and GLP-1-containing co-agonists, are...
